World's Best Scientists 2026 revealed!

D-Index & Metrics

Microbiology

D-Index
83
Citations
22996
World Ranking
1003
National Ranking
457

Overview

Jan Novak is affiliated with the University of Alabama at Birmingham in the United States and has an extensive research portfolio primarily focused on medicine and immunology. Their work encompasses significant contributions in nephrology, immunology, and molecular biology with notable intersections in radiology, nuclear medicine, imaging, and hematology.

Their research extensively addresses topics related to renal diseases and glomerulopathies, glycosylation and glycoproteins research, monoclonal and polyclonal antibodies research, platelet disorders and treatments, celiac disease research and management, the complement system in diseases, and autoimmune bullous skin diseases.

Novak's recent published papers include:

  • Pathogenesis of IgA Nephropathy: Current Understanding and Implications for Development of Disease-Specific Treatment, 2021, Journal of Clinical Medicine
  • IgA vasculitis with nephritis: update of pathogenesis with clinical implications, 2021, Pediatric Nephrology
  • IgA glycosylation and immune complex formation in IgAN, 2021, Seminars in Immunopathology
  • Experimental evidence of pathogenic role of IgG autoantibodies in IgA nephropathy, 2021, Journal of Autoimmunity
  • Genetic regulation of serum IgA levels and susceptibility to common immune, infectious, kidney, and cardio-metabolic traits, 2022, Nature Communications

Frequent co-authors collaborating with Novak include:

  • Bruce A. Julian (collaborated on 36 publications)
  • Stacy Hall (32 publications)
  • Colin Reily (28 publications)
  • Matthew B. Renfrow (24 publications)
  • Dana V. Rizk (22 publications)

Novak's research findings are published in various venues with a concentration in the following journals and platforms:

  • Journal of the American Society of Nephrology (30 publications)
  • Journal of Clinical Medicine (6 publications)
  • arXiv (Cornell University) (5 publications)
  • Kidney International Reports (4 publications)
  • bioRxiv (Cold Spring Harbor Laboratory) (4 publications)

Best Publications

  • Glycosylation in health and disease.

    Colin Reily;Tyler J. Stewart;Matthew B. Renfrow;Jan Novak

  • The Pathophysiology of IgA Nephropathy

    Hitoshi Suzuki;Krzysztof Kiryluk;Jan Novak;Zina Moldoveanu

  • Genome-wide association study identifies susceptibility loci for IgA nephropathy

    Ali G Gharavi;Krzysztof Kiryluk;Murim Choi;Yifu Li

  • Discovery of new risk loci for IgA nephropathy implicates genes involved in immunity against intestinal pathogens

    Krzysztof Kiryluk;Yifu Li;Francesco Scolari;Simone Sanna-Cherchi

  • Circulating immune complexes in IgA nephropathy consist of IgA1 with galactose-deficient hinge region and antiglycan antibodies

    Milan Tomana;Jan Novak;Bruce A. Julian;Karel Matousovic

  • Naturally Occurring Human Urinary Peptides for Use in Diagnosis of Chronic Kidney Disease

    David M. Good;Petra Zürbig;Àngel Argilés;Hartwig W. Bauer

  • Muscle-specific microRNAs in skeletal muscle development

    Martin Horak;Jan Novak;Julie Bienertova-Vasku

  • Aberrantly glycosylated IgA1 in IgA nephropathy patients is recognized by IgG antibodies with restricted heterogeneity

    Hitoshi Suzuki;Run Fan;Zhixin Zhang;Rhubell Brown

  • Patients with IgA nephropathy have increased serum galactose-deficient IgA1 levels.

    Z. Moldoveanu;R.J. Wyatt;J.Y. Lee;M. Tomana

  • Geographic Differences in Genetic Susceptibility to IgA Nephropathy: GWAS Replication Study and Geospatial Risk Analysis

    Krzysztof Kiryluk;Yifu Li;Simone Sanna-Cherchi;Simone Sanna-Cherchi;Mersedeh Rohanizadegan

  • Current Understanding of the Role of Complement in IgA Nephropathy

    Nicolas Maillard;Nicolas Maillard;Robert J. Wyatt;Bruce A. Julian;Krzysztof Kiryluk

  • Clinical proteomics: A need to define the field and to begin to set adequate standards.

    Harald Mischak;Rolf Apweiler;Rosamonde E. Banks;Mark Conaway

  • IgA1-secreting cell lines from patients with IgA nephropathy produce aberrantly glycosylated IgA1

    Hitoshi Suzuki;Zina Moldoveanu;Stacy Hall;Rhubell Brown

  • Recommendations for Biomarker Identification and Qualification in Clinical Proteomics

    Harald Mischak;Guenter Allmaier;Rolf Apweiler;Teresa Attwood

  • Advances in Urinary Proteome Analysis and Biomarker Discovery

    Danilo Fliser;Jan Novak;Visith Thongboonkerd;Àngel Argilés

  • Aberrant IgA1 Glycosylation Is Inherited in Familial and Sporadic IgA Nephropathy

    Ali G. Gharavi;Zina Moldoveanu;Robert J. Wyatt;Catherine V. Barker

  • Urinary Proteomics in Diabetes and CKD

    Kasper Rossing;Harald Mischak;Mohammed Dakna;Petra Zürbig

  • Autoantibodies Targeting Galactose-Deficient IgA1 Associate with Progression of IgA Nephropathy

    Francois Berthoux;Francois Berthoux;Hitoshi Suzuki;Lise Thibaudin;Lise Thibaudin;Hiroyuki Yanagawa

  • Mice overexpressing BAFF develop a commensal flora–dependent, IgA-associated nephropathy

    Douglas D. McCarthy;Julie Kujawa;Cheryl Wilson;Adrian Papandile

  • Body fluid proteomics for biomarker discovery: lessons from the past hold the key to success in the future.

    David M. Good;Visith Thongboonkerd;Jan Novak;Jean-Loup Bascands

  • Aberrant glycosylation of IgA1 is inherited in both pediatric IgA nephropathy and Henoch–Schönlein purpura nephritis

    Krzysztof Kiryluk;Zina Moldoveanu;John T. Sanders;John T. Sanders;T. Matthew Eison;T. Matthew Eison

  • The level of galactose-deficient IgA1 in the sera of patients with IgA nephropathy is associated with disease progression

    Na Zhao;Ping Hou;Jicheng Lv;Zina Moldoveanu

  • IgA glycosylation and IgA immune complexes in the pathogenesis of IgA nephropathy.

    Jan Novak;Bruce A. Julian;Milan Tomana;Jiri Mestecky;Jiri Mestecky

  • IgA1-containing immune complexes in IgA nephropathy differentially affect proliferation of mesangial cells

    Jan Novak;Milan Tomana;Milan Tomana;Karel Matousovic;Karel Matousovic;Karel Matousovic;Rhubell Brown;Rhubell Brown

  • Patients with igA nephropathy have increased serum galactose-deficient igA1 levels. Commentary

    A. Roos;C. Van Kooten;Z. Moldoveanu;R. J. Wyatt

Frequent Co-Authors

Bruce A. Julian
Bruce A. Julian University of Alabama at Birmingham
Jiri Mestecky
Jiri Mestecky University of Alabama at Birmingham
Zina Moldoveanu
Zina Moldoveanu University of Alabama at Birmingham
Milan Tomana
Milan Tomana University of Alabama at Birmingham
Ali G. Gharavi
Ali G. Gharavi Columbia University
Yasuhiko Tomino
Yasuhiko Tomino Juntendo University
Harald Mischak
Harald Mischak University of Glasgow
Joshua J. Coon
Joshua J. Coon University of Wisconsin–Madison
Visith Thongboonkerd
Visith Thongboonkerd Mahidol University
Anna F. Dominiczak
Anna F. Dominiczak University of Glasgow

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring microbiology can open doors to diverse career options, often linked with healthcare, research, and education. For those considering advanced studies, there are several related online degrees that offer flexible learning and accessible admission processes. For instance, many students look into mph online programs with easy admission requirements, which combine public health knowledge with microbiology expertise, preparing graduates for impactful careers.

Careers tied to microbiology extend beyond the lab. Roles such as child life specialists require both scientific understanding and compassionate skills. If you are interested in this path, learning about the certified child life specialist salary can provide valuable insight into the profession’s rewards and opportunities.

Education pathways are evolving to support inclusivity. For individuals with past convictions seeking fresh starts, discovering college degrees for felons can be a crucial step in building a microbiology-related career with fewer barriers.

Another career avenue merging science and patient care is becoming a functional medicine nurse practitioner. To understand this journey, resources on how to become a functional medicine nurse practitioner offer detailed guidance on education and certification requirements.

Best Scientists Citing Jan Novak

Trending Scientists

Recently Published Articles